Skip to content

Acupuncture versus metoprolol for interval treatment of migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18249834
Enrollment
115
Registered
2005-07-29
Start date
2002-10-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Nervous System Diseases Migraine

Interventions

Individualised acupuncture (up to 15 sessions) or 100 to 200 mg metoprolol

Sponsors

Munich Technical University - Centre for Complementary Medicine Research (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients with migraine fulfilling the criteria of the International Headache Society (planned number of participants was 480; recruitment had to be terminated early, in summer 2004, due to recruitment problems and time limits of the project after recruiting 115 patients)

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026